Table 6.

List of the 35 most frequent BCR-ABL1 kinase domain mutations associated with resistance to TKIs (based on the integration of in vitro IC50 data and in vivo observations)

MutationTKI(s) to which the mutation confers resistance
M244V Imatinib 
L248V Imatinib 
G250E Imatinib 
Q252H Imatinib 
Y253H Imatinib, nilotinib 
E255V Imatinib, nilotinib, bosutinib 
E255K Imatinib, nilotinib, bosutinib 
L273M Imatinib 
D276G Imatinib 
T277A Imatinib 
E279K Imatinib 
V299L Dasatinib, bosutinib 
F311L Imatinib 
T315I Imatinib, nilotinib, dasatinib, bosutinib 
T315A Dasatinib 
T315M Ponatinib 
T315L Ponatinib 
F317L Imatinib, dasatinib 
F317V Imatinib, dasatinib 
F317I Imatinib, dasatinib 
F317C Imatinib, dasatinib 
M351T Imatinib 
E355G Imatinib 
F359C Imatinib, nilotinib 
F359I Imatinib, nilotinib 
F359V Imatinib, nilotinib 
E379K Imatinib 
L384M Imatinib 
L387M Imatinib 
L387F Imatinib 
H396R Imatinib 
H396P Imatinib 
E459K Imatinib 
F486S Imatinib 
MutationTKI(s) to which the mutation confers resistance
M244V Imatinib 
L248V Imatinib 
G250E Imatinib 
Q252H Imatinib 
Y253H Imatinib, nilotinib 
E255V Imatinib, nilotinib, bosutinib 
E255K Imatinib, nilotinib, bosutinib 
L273M Imatinib 
D276G Imatinib 
T277A Imatinib 
E279K Imatinib 
V299L Dasatinib, bosutinib 
F311L Imatinib 
T315I Imatinib, nilotinib, dasatinib, bosutinib 
T315A Dasatinib 
T315M Ponatinib 
T315L Ponatinib 
F317L Imatinib, dasatinib 
F317V Imatinib, dasatinib 
F317I Imatinib, dasatinib 
F317C Imatinib, dasatinib 
M351T Imatinib 
E355G Imatinib 
F359C Imatinib, nilotinib 
F359I Imatinib, nilotinib 
F359V Imatinib, nilotinib 
E379K Imatinib 
L384M Imatinib 
L387M Imatinib 
L387F Imatinib 
H396R Imatinib 
H396P Imatinib 
E459K Imatinib 
F486S Imatinib 

or Create an Account

Close Modal
Close Modal